SCHEMBL6500699

SCHEMBL6500699

CCOC(=O)C1CCN(c2cncc3ccccc23)CC1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 6/20 0.55
KDM4E B2RXH2 5/20 0.54
APOBEC3A P31941 1/20 0.54
APOBEC3G Q9HC16 1/20 0.54
GAA P10253 1/20 0.53
ALDH1A1 P00352 4/20 0.53
MAPK1 P28482 2/20 0.53
HSD17B10 Q99714 2/20 0.53
MEN1 O00255 2/20 0.52
KMT2A Q03164 2/20 0.52
HPGD P15428 2/20 0.52
NPSR1 Q6W5P4 2/20 0.52
TP53 P04637 2/20 0.52
CTSB P07858 1/20 0.52
LGMN Q99538 1/20 0.51
TSHR P16473 2/20 0.50
SMN1; SMN2 Q16637 1/20 0.50
CDK8 P49336 1/20 0.49
CYP11B1 P15538 1/20 0.49
CYP11B2 P19099 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30637195 0.87 ALDH1A1 (0.55) MAPTKDM4EGAAALDH1A1MAPK1
SCHEMBL27649150 0.83 CDK8 (0.47) KDM4EALDH1A1MAPK1MEN1KMT2A
SCHEMBL6506837 0.81 CYP11B2 (0.53) KDM4EALDH1A1MEN1KMT2ACDK8
SCHEMBL899745 0.78 KMT2A (0.74) MAPTKDM4EALDH1A1MEN1KMT2A
SCHEMBL2165481 0.77 ALDH1A1 (0.67) MAPTKDM4EGAAALDH1A1MEN1
SCHEMBL3436315 0.77 ALDH1A1 (0.64) MAPTKDM4EALDH1A1HSD17B10MEN1
SCHEMBL6186988 0.77 MAPT (0.57) MAPTKDM4EALDH1A1MAPK1MEN1
SCHEMBL18914465 0.77 MEN1 (0.65) MAPTKDM4EAPOBEC3AAPOBEC3GGAA
SCHEMBL5780030 0.76 CYP11B2 (0.48) CDK8CYP11B1CYP11B2
SCHEMBL5812793 0.76 GAA (0.57) MAPTKDM4EGAAALDH1A1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005019200-A2 ARYL PIPERIDINE DERIVATIVES AS VLA-1 INTEGRIN ANTAGONISTS AND USES THEREOF ICOS CORPORATION (US) 2005-03-03 WO disclosed